Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × sintilimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Solid Tumor 1 Recurrence 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Lung Squamous Cell Carcinoma 1 Locally Recurrent Rectal Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 Hemangiosarcoma 1 Gastric Adenocarcinoma 1

Interventions

Carboplatin 36 Etoposide 34 durvalumab 29 atezolizumab 21 PM 01183 14 pembrolizumab 13 Topotecan 13 Cisplatin 13 Nivolumab 10 Paclitaxel 9 Drug Therapy 9 Specimen Handling 8 Platinum 8 Temozolomide 7 AMG 757 7 olaparib 6 anlotinib 6 Radiosurgery 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Docetaxel 6 berzosertib 5 Radiotherapy 5 Bevacizumab 5 trilaciclib 4 tremelimumab 4 Irinotecan 4 Biopsy 4 toripalimab 3 tislelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡